|
SMG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.856600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.054400E-01 |
| Normal-vs-Stage2 |
4.894600E-01 |
| Normal-vs-Stage3 |
8.786400E-01 |
| Normal-vs-Stage4 |
3.187000E-01 |
| Stage1-vs-Stage2 |
3.963600E-01 |
| Stage1-vs-Stage3 |
8.017400E-01 |
| Stage1-vs-Stage4 |
4.937000E-01 |
| Stage2-vs-Stage3 |
6.499600E-01 |
| Stage2-vs-Stage4 |
2.857000E-01 |
| Stage3-vs-Stage4 |
4.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.987000E-01 |
| Normal-vs-AfricanAmerican |
6.067600E-01 |
| Normal-vs-Asian |
2.814000E-01 |
| Caucasian-vs-AfricanAmerican |
2.251400E-01 |
| Caucasian-vs-Asian |
4.054200E-01 |
| AfricanAmerican-vs-Asian |
6.325600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.372200E-01 |
| Normal-vs-Female |
2.101200E-01 |
| Male-vs-Female |
2.573400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.486000E-01 |
| Normal-vs-Extreme_Weight |
2.963400E-01 |
| Normal-vs-Obese |
1.624410E-01 |
| Normal-vs-Extreme_Obese |
4.811200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.178400E-01 |
| Normal_Weight-vs-Obese |
2.327800E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.999400E-01 |
| Extreme_Weight-vs-Obese |
2.406200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.018000E-01 |
| Obese-vs-Extreme_Obese |
2.111200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.036600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.396500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.585000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.821600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.246000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.333200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.555900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.733510E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.720000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.449800E-01 |
| Normal-VS-Type2 PRCC |
4.343700E-02 |
| Normal-VS-KIRP CIMP |
4.713000E-01 |
| Normal-VS-Unclassified PRCC |
1.140990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.12079999999793E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.436200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.751600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.744200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.822300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.935800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.569600E-01 |
| Normal-vs-N1 |
7.117200E-01 |
| Normal-vs-N2 |
4.236400E-01 |
| N0-vs-N1 |
3.017400E-01 |
| N0-vs-N2 |
7.885200E-01 |
| N1-vs-N2 |
4.714000E-01 |
|
|
